Abstract
Protein turnover in the brain proceeds at a high rate in all developmental stages. This high activity indicates that not only protein synthesis but also protein degradation occurs at high rates. Information IS available about the rate, mechanism, and regulatory factors of protein synthesis m the nervous system, but comparable knowledge on protein breakdown is not yet available (Marks and Lajtha, 1971; Hui and Lajtha, 1983).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Almenoff J., Wilk S., and Orlowski M. (1981) Membrane-bound pituitary metalloendopeptidase: Apparent identity to enkephalmase. Biochem Biophys. Res. Commun 102, 206–214.
Aoki Y., Urata G., Takatsia F., and Katunuma N. (1975) A new protease mactivating a-aminolevulinic acid synthetase in mitochondria of human bone marrow cells. Biochem. Biophys. Res. Commun. 65, 567–574.
Aoyagi T. (1978) Structure and Activities of Protemase Inhibitors of Microbial Origin, in Bioactive Peptides Produced by Microorganisms (Umezawa H., Takita T., and Shiba T., eds.), Kodansha, Tokyo.
Arregui A., MacKay A. V. P., Iversen L L., and Spokes E. G (1979) Reduction of angiotensin-converting enzyme in substantia nigra in early-onset schizophrenia. N Engl J. Med. 30, 502–503
Arregui A., MacKay A. V. P, Spokes E. G., and Iversen L. L. (1980) Reduced activity of angiotensin-converting enzyme in basal ganglia in early onset schizophrenia. Psychol Med. 10, 307–313.
Arstila A. V, Reikkinen P. J, Rinne U. K., Pellinieme T. T, and Nevalamen T. (1971) Guillain-Barre syndrome. Neurochemical and ultrastructural study. Eur. Neurol. 5, 257–269.
Barrett A. J., Elisabeth Davies M, and Grubb A. (1984) The place of human β-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochem. Biophys. Res. Commun. 120, 631–636.
Benson J. R. and Hare, H. E (1975) o-Phthaldialdehyde fluorogenic detection of primary amines in the picomole range comparison with fluorescamine and ninhydrin. Proc Natl. Acad. Sci. USA 72, 619–622.
Berg M. J. and Marks N. (1984) Formation of des Tyr dynorphms 5–17 by a purified cytosolic aminopeptidase of rat brain. J. Neurosci. Res. 11, 313–321
Boehme D H, Umezawa H., Hashim G., and Marks N (1978) Treatment of experimental allergic encephalomyelitis with an inhibitor of cathepsin D (pepstatin). Neurochem. Res 3, 185–194.
Bowen D M, Smith C. B, and Davison A. N (1973) Molecular changes in senile dementias. Brain 96, 849–856.
Brosnan C. F., Cammer W, Norton W. T., and Bloom B. R (1980) Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis. Nature 285, 235–237.
Burbach J. P H., De Kloet E. R, and De Wied D (1980) Oxytocin biotransformation in the rat limbic brain. Characterization of peptidase activities and significance in the formation of oxytocin fragments. Brain Res. 202, 401–414.
Burzynski S. R. (1975) Quantitative analysis of amino acids and peptides in the femtomolar range. Anal. Biochem. 65, 93–99.
Byers L D. and Wolfenden R. (1973) Binding of the by-product analog benzylsuccinic acid by carboxypeptidase A. Biochemistry 12, 2070–2078
Carmago A. C. M., Shapanka R., and Greene L. J. (1973) Preparation, assay and partial characterizatin of a neutral endopeptidase from rabbit brain. Biochemistry 12, 1838–1844.
Chan W. W. C. (1983) Leucinthlol—a potent inhibitor of leucine aminopepudase. Biochem. Biophys. Res. Commun. 116, 297–302.
Chan W. W. C., Dennis P., Demmer W., and Brand K. (1982) Inhibition of leucine aminopeptidase by amino acid hydroxamates. J. Biol Chem. 257, 7955–7957.
Chelmicka-Schorr E. E., Arnason B. E. W., Astrom K.-E., and Darzynkiewicz Z. (1978) Treatment of mouse muscular dystrophy with the protease inhibitor pepstatm. J. Neuropathol. Exp. Neurol. 37, 263–268.
Cushman D. W., Cheng H. S., Sabo E. F., and Ondetti M. A. (1977) Design of potent competitive inhibitors of angiotensin-converting Enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochemistry 16, 5484–5491.
Dean D. D and Woessner F., Jr. (1984) Extracts of human articular cartilage contain an inhibitor of tissue metalloproteinases. Biochem. J. 218, 277–280.
De La Baume S., Yi C. C., Schwartz J. C., Chaillet P., Marcais-Collado H., and Costentin J. (1983) Participation of both “enkephalinase” and aminopeptidase activities in the metabolism of endogenous enkephalins. Neuroscience 8, 143–151.
Devi L. and Goldstein A. (1984) Dynorphin converting enzyme with unusual specificity from rat brain. Proc. Natl. Acad. Sci. USA 81, 1892–1896.
Einstein E. R., Csejtey J., Dalal K. B., Adams C. W. M., Bayliss O. B., and Hallpike J. F. (1972) Proteolytic activity and basic protein loss in and around multiple sclerosis plaques. Combined biochemical and histochemical observations. J. Neurochem. 12, 653–662.
Einstein E. R., Dalal K. B., and Csejtey J. (1970) Increased protease activity and changes in basic proteins and lipids in multiple sclerosis plaques. J Neurol. Sci 11, 109–121.
Erlanger B. F., Kokowsky N., and Cohen W. (1961) The preparation and properties of two new chromogenic substrates of trypsin. Arch. Biochem. Biophys 95, 271–278.
Feinstein G., Kupfer A, and Sokolovsky M. (1973) N-Acetyl-(l-Ala) 3-p-nitroanilide as a new chromogenic substrate for elastase. Biochem. Biophys. Res. Commun. 50, 1020–1026.
Fricker L. D. and Snyder S H. (1982) Enkephalin convertase: Purification and characterization of a specific enkephalin-synthesizing carboxypeptidase localized to adrenal chromaffin granules. Proc Natl Acad. Sci. USA 79, 3886–3890.
Fruton J. S. (1960) Cathepsins, in The Enzymes 2nd Ed. (Boyer P. D., Lardy H., and Myrback K., eds.), Academic, New York.
Gráf L., Cseh G, Barát E, Ronai A., Székely J I., Kenessey A., and Balusz S. (1977) Structure-function relationship in lipotropins. Ann NY Acad. Sci 297, 63–83.
Gráf L., Kenessey A, Bajusz S., Patthy A., Ronai A Z., and Berzétei I. (1979) Proteolytic Processing in the Biosynthesis and Metabolism of Endorphins, in Endorphin in Mental Health Research (Usdin W. E., Bunney J., and Kline N. S., eds.), MacMillan, New York.
Green G D. J, Kembhavi A. A., Davies M. E., and Barrett A. J. (1984) Cystatin-like cysteine proteinase inhibitors from human liver. Biochem. J. 218, 939–946.
Hamilton P. B. (1963) Ion exchange chromatography of amino acids, a single column, high resolving, fully automatic procedure. Anal Chem. 35, 2055–2064
Hancock W. S., Bishop C. A., and Hearn M. T. W (1979) The analysis of nanogram levels of free amino acids by reverse-phase high-pressure liquid chromatography. Anal. Biochem. 92, 170–178.
Hersh L. B. (1981) Solubilizahon and characterization of two rat brain membrane-bound aminopeptidases active on Met-enkephalin. Biochemtsty 20, 2345–23
Hersh L. B. (1985) Characterization of membrane-bound ammopepndases from rat brain. Identification of the enkephalm-degrading aminopeptidase. J Neurochem. 44, 1427–14
Hill D. W., Walters F. H., Wilson T. D., and Stuart J. D. (1979) High performance liquid chromatographic determination of amino acids in the picomole range. Anal Chem 51, 1338–1341.
Hui K.-S. and Lajtha A. (1978) Prolidase activity in the brain. Comparison with other organs. J Neurochem. 30, 321–327.
Hui K.-S. and Lajtha A. (1983) Neuropeptides, in Handbook of Neurochemisty, 2ndEd,Vol 4, (Lajtha A.,Ed.), Plenum, New York and London.
Hui K.-S., Cheng K.-P., Wong K.-H., Salshutz M., and Lajtha A. (1980a) Degradation of melanotropin inhibiting factor by bram. J Neurochem 35, 471–478.
Hui K.-S., Salshutz M., Davis B. A., and Lajtha A. (1980b) Separation of alkylaminonaphthylenesulfonyl peptides and amino acids: Methods for measuring melanotropin inhibiting factor breakdown. J. Chromatogr 192, 341–350
Hui K.-S., Gráf L., and Lajtha A. (1982) β-Endorphin inhibits Metenkephalin breakdown by a brain ammopeptidase: Structure-activity relationships. Biochem. Brophys. Res. Commun. 105, 1482–1487.
Hui K.-S., Hui M., Banay-Schwartz M., DeGuzman T., Ling N., and Lajtha A. (1983a) Enkephalin-containing polypeptides are potent inhibitors of enkephalin degradation. Peptides 4, 639–646.
Hui K-S., Wang Y.-J, and Lajtha A. (1983b) Purification and characterization of an enkephalin ammopeptidase from rat brain membrane. Blochemstry 22, 1062–1067
Hui K.-S., Wang Y.-J., Wong K.-H., Tsai H., and Lajtha A. (1981) Regional and subcellular distribution of Met-and Leu-enkephalin-degrading activity in rat brain. Neuropeptides 1, 167–173.
International Union of Biochemistry (1978) Recommendations of the nomenclature committee of the International Union of Biochemistry. Academic, New York
Kellokumpu S., Vuolteenaho O., and Leppaluoto J. (1980) Behavior of rat hypothalamic and extrahypothalamic immunoreacuon TRF in thinlayer chromatography (TLC) and high pressure liquid chromatography (HPLC). Life Sci 26, 475–480.
Kelly J. A., Needle E. L., and Needle A. (1983) An aminopeptidase from mouse brain cytosol which cleaves N-terminal acidic amino acid residues. J. Neurochem. 40, 1727–1734.
Kojima K., Hama T., Kato T., and Nagatsu T. (1980) Rapid chromatographic purification of dipeptidyl peptidase IV in human submaxillary gland. J. Chromatogr. 189, 233–240.
Kominami E., Uakamatsa N., and Katunuma N. (1982) Purification and characterization of thiol proteinase inhibitor from rat liver. J. Biol. Chem. 257, 14648–14652.
Kopitar M., Stern F, and Marks N. (1983) Cerebrocystatin suppresses degradation of myelin basic protein by purified brain cysteine proteinase. Biochem Biophys Res. Commun. 112, 1000–1006.
Kuehn L., Rutschmann in, Dahlmann B., and Reinauer H. (1984) Protemase inhibitors in rat serum. Biochem J. 218, 953–959.
Laskowski M., Jr. and Kato I. (1980) Protein inhibitors of proteinases. Ann. Rev Biochem. 49, 593–626
Libby P. and Goldberg A. L. (1978) Leupeptin, a protease inhibitor, decreases protein degradation in normal and diseased muscles Science 199, 534–536.
Marks N. and Lajtha A. (1963) Protein breakdown in brain: Subcellular distribution of neural and acid proteinases. Biochem. J. 89, 438–477.
Marks N. and Lajtha A. (1971) Protein and Polypeptide Breakdown, in Handbook of Neurochemistry, Vol. V, Part A, (Lajtha A., ed ), Plenum, New York.
Marks N., Berg M. J, Kastin A. J., and Coy D. H (1984) Evidence for conversion of N-Tyr-MIF-1 into MIF-1 by a specific brain aminopepudase. Neurochem. Int. 6, 347–353
Marks N, Datta R. K., and Lajtha A. (1968) Partial resolution of brain arylamidases and aminopeptidases. J. Biol. Chem. 243, 2882–2889.
Nagase H. and Harris E. D., Jr. (1983) Ovostatin-A novel proteinase inhibitor from chicken egg white. J. Biol. Chem. 258, 7481–7489
Neidle A. and Lajtha A. (1976) The Substrate Specificity of an Aminopepudase (Neutral arylamidase) From Pig Brain, in Problems of Brain Biochemistry Vol. XI, (Buinatian H. Ch., ed ), Armenian Acad. Sci., Yerevan, CCCP.
Neidle A., Yessaian N., and Lajtha A. (1980) Degradation of prolylleucyl-glycinamide (MIF) by mouse brain. Neurochem. Res. 5, 1011–1023.
Nishino N. and Powers J. C. (1980) Pseudomonas aeruginosa elastase; Development of a new substrate, inhibitors, and an affinity ligand. J Biol. Chem. 255, 3482–3486.
Nishizawa R, Saino T., Takita T., Suda H, Aoyagi T., and Umezawa H (1977) Synthesis and structure-activity relationships of bestatin analogues, inhibitors of ammopeptidase J. Med Chem. 20, 510–515.
Ondetti M. A (1983) Biochemistry of the renin-angiotensin system. Introduction Fed Proc. 42, 2722–2723.
Orlowski M. (1983) Protemases, in Handbook of Neurochemistry, 2nd Ed., Vol. 4 (Lajtha A., Ed.), Plenum, New York
Orlowski M., Orlowski J., Lesser M., and Kiburn K. H. (1981) Proteolytic enzymes in bronchopulmonary lavage fluids: Cathepsin B-like activity and prolyl endopeptidase. J. Lab. Clin. Invest. 97, 467–476.
Orlowski M., Wilk E., Pearce S., and Wilk S. (1979) Purification and properties of a prolyl endopeptidase from rabbit brain. J Neurochem 33, 461–469.
Patchett A. A., Harris E, Tristram E W., Wyrratt M J., Wu M. T., Taub D., Paterson E R., Ikeler T. J., Ten Broeke J., Payne L. G., Ondeyka D. L., Thorsett E. D., Greenlee W. J., Lohr N. S., Hoffsommer R. D., Joshua H., Ruyle W. V., Rothrock J. W., Aster S. D., Maycock A. L., Robinson F. M., Hirschmann R., Sweet C S., UIm E. H., Gross D. M., Vassil T. C., and Stone C. A. (1980) A new class of angiotensin-converting enzyme inhibitors. Nature 288, 280–281.
Patey G., De La Baume S., Schwartz J.-C., Gros C., Roques B., Fournie-Zaluski M.-C., and Soroca-Lucas E. (1981) Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition. Science 212, 1153–1155.
Pinsky C., Dua A. K., and LaBella F. S. (1982) Peptidase inhibitors reduce opiate narcotic withdrawal signs, including seizure activity in the rat brain. Brain Res 243, 301–307.
Pontremoli S., Melloni E., Salamino F., Sparatone B., Michett M., and Horecker B. L. (1983) Endogenous inhibitors of lysosomal protemases. Proc. Natl. Acud. Sci. USA 80, 1261–1264.
Pope A. (1968) Structural and Enzymatic Microchemistry of Human Cerebral Cortex, in The Central Nervous System (Bailey O. T. and Smith D. E., Ed.), Williams & Wilkins, Baltimore, Maryland.
Pope A. and Nixon R. A. (1984) Proteases of human brain. Neurochem. Res. 9, 291–323.
Pope A., Hess H. H., and Lewin E. (1964) Studies on the Microchemical Pathology of Human Cerebral Cortex, in Morphological and Biochemical Correlates of Neural Activity (Cohen M. M. and Snider R. S., eds.), Hoeber-Harper, New York.
Relth M. E. A. and Neidle A. (1979) The isolation of two dipeptide hydrolases from mouse brain cytosol. Biochem. Brophys. Res. Commun. 90, 794–800.
Relton J. M., Gee N. S., Matsas R., Turner A. J., and Kenny A. J. (1983) Purification of endopeptidase-24,11 (enkephalinase) from pig brain by immunoadsorbent chromatography. Biochem. J. 215, 519–523.
Roques B. P., Fournie-Zaluski M. C., Soroca E., Lecomte J. M., Malfroy B., Llorens C., and Schwartz J.-C (1980) The enkephalinase inhibitor throrphan shows antinocrceptrve activity in mice. Nature 288, 286–288.
Sacks L. and Marks N. (1982) A highly specific aminotripeptidase of rat brain cytosol: Substrate specificity and effects of inhibrtors. Biochim. Biophys. Acta 706, 229–238.
Saito M., Aoyagi T, Umezawa H., and Nagai Y. (1977) Bestatin, A new specific inhibitor of ammopeptrdase, enhances achvation of small lymphocytes by concanavalin A. Biochem. Biophys. Res. Commun. 76, 526–533.
Saito M., Yoshizawa T., Aoyagi T., and Nagai Y. (1973) Involvement of proteolytic activity in early events in lymphocyte transformation by phytohemagglutmin. Biochem. Biophys. Res. Commun. 52, 569–575.
Samejima K., Dairman W., and Udenfriend S. (1971) Condensation of ninhydrin with aldehydes and primary ammes to yield highly fluorescent ternary products, Studies on the mechanism of the reaction and some characterishcs of the condensation product. Anal. Biochem. 42, 222–236.
Schlaepfer W. W (1978) Deformation of isolated neurofilaments and the pathogenesis of neuroflbrillary pathology. J. Neuropafhol. Exp. Neurol 37, 244–254.
Schwartz J.-C., Malfroy B., and De La Baume S. (1981) Brological inactivation of enkephalins and the role of enkephalm-dipeptidylcarboxy-peptidase (enkephahnase) as neuropeptidase. Life Sci. 29, 1715–1740.
Shaw E. (1970) Selective chemical modrfication of protein. Physlol. Rev. 50, 244–296.
Sher J. H., Stracher A., Shafiq S. A., and Hardy-Stashin J. (1981) Successful treatment of murine muscular dystrophy with the proteinase inhibitor leupeptin. Proc. Natl. Acad. Sci. USA 78, 7742–7744.
Shimamura M., Hazato T., and Katayama T. (1983) A membrane-bound ammopeptidase isolated from monkey and its action on enkephalin. Biochim. Biophys. Acta 756, 223–229.
Somack R. (1980) Complete phenylthiohydantoin ammo acid analysis by high performance chromatography on ultrasphere-octadecyltri-methyloxylsilane. Anal. Biochem. 104, 464–468.
Stahlhut R. W. and Hymowltz T. (1983) Variation in the low molecular weight proteinase inhibitors of soybeans. Crop Sci. 23, 766–769.
Stein S. (1980) Ultramicro Isolation and Analysis of Peptides and Proteins, in Polypeptide Hormones (Beers R. F. and Bassett E. G., eds.), Raven, New York.
Stein S., Bohlen P., Stone J., Dairman W., and Udenfriend S. (1973) Amino acid analysis with fluorescamine at the picomole level Arch. Biochem. Biophys. 155, 202–212.
Steiner D. F., Quinn P. S., Chan S. J., Marsh J., and Tager H. S. (1980) Processmg mechanisms in the biosynthesis of proteins. Ann NY Acud. Sci. 343, 1–16
Stern F. and Marks N (1979) Glycyl-glycine hydrolase of rat brain: Distribution and role in cleavage of glycine-rich oligopeptides. Brain Res. Bull. 4, 49–55.
Supattapone S., Fricker L. D., and Snyder S H. (1984) Purification and characterization of a membrane-bound enkephalin-forming carboxypeptidase, “enkephalin convertase.” J. Neurochem. 42, 1017–1023.
Swerts J. P., Perdrisot R., Malfroy B., and Schwartz J.-C. (1979) Is “enkephalmase” identical with “angiotensin-converting enzyme?” Eur. J. Pharmacol. 53, 209–210.
Takahara H and Sinohara H. (1982) Mouse plasma trypsin inhibitor: Isolation and characterization of α-1-antitrypsin and contrapsin, a novel trypsin inhibitor. J. Biol. Chem. 257, 2438–2446.
Thorsett E. D., Harris E. E., Paterson E. R., Greenlee W. J., Patchett A. A., Ulm E H., and Vassil T. C. (1982) Phosphorus-containing inhibitors of angiotensin-converting enzyme Proc. Natl. Acad. Sci. USA 79, 2176–2180.
Travis T. and Salvesen G. S. (1983) Human plasma proteinase inhibitors. Ann. Rev. Btochem. 52, 655–709.
Turner A. J., Matsas R., and Kenny A J. (1985) Are there neuropeptide-specific peptidases? Bzochem. Pharmacol 34, 1347–1356.
Umezawa H., Takita T, and Shiba T.(1978) Bioactive Peptides Produced by Microorganisms. Kodansha, Tokyo.
Wallace E. F., Weber E, Barchas J. D., and Evans C. J (1984) A putative processmg enzyme from Aplysia that cleaves dynorphin A at the single arginine residue. Biochem. Blophys Res Commun 119, 415–422.
Walsh K. A. (1975) Unifymg Concepts Among Proteases, in Proteases and Biological Control (Reich E., Rifkin D. B., and Shaw E., eds.), Cold Spring Harbor Laboratory, New York.
Zhang A.-Z., Yang H.-Y.T., and Costa E. (1982) Nociception, enkephalm content and dipeptidyl carboxypeptidase activity in brain of mice treated with exopeptrdase inhibitors. Neurophurmacology 21, 625–630.
Zubenko G. S. and Nixon R. A. (1984) Mood-elevating effect of captoprll in depressed patrents. Am. J. Psychiatry 141, 110–111.
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1986 The Humana Press Inc.
About this protocol
Cite this protocol
Hui, KS., Lajtha, A. (1986). Proteinases and Peptidases. In: Boulton, A.A., Baker, G.B., Yu, P.H. (eds) Neurotransmitter Enzymes. Neuromethods, vol 5. Humana Press. https://doi.org/10.1385/0-89603-079-2:421
Download citation
DOI: https://doi.org/10.1385/0-89603-079-2:421
Publisher Name: Humana Press
Print ISBN: 978-0-89603-079-4
Online ISBN: 978-1-59259-610-2
eBook Packages: Springer Protocols